News
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Five years after the COVID-19 pandemic shutdown reshaped how the world gathers, here's how some of ophthalmology’s leading ...
A new event called SightLine and a series on adoption, implementation, integration (AII) draw the attention of ophthalmic ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
The FDA did not agree with a supplemental Biologics License Application for the addition of extended dosing intervals of up ...
The affected mandate requires that all newborns receive erythromycin ointment applied to their eyes after birth, which helps ...
CsA Ophthalmic Gel is an innovative cyclosporine gel being developed by Zhaoke in China for the treatment of moderate to ...
In honor of Ophthalmology Times’ 50th anniversary, we asked a panel of leading ophthalmologists and optometrists across ...
Authors defined metabolic syndrome as “the set of factors that increase the risk of cardiovascular disease and diabetes, such ...
A survey collected demographic data, ocular and medical history, and responses assessing knowledge of glaucoma and cataracts ...
Leos is supported by emerging data from a randomized controlled clinical trial, further validating its safety and efficacy.
Regeneron aims for FDA approval of extended dosing for EYLEA HD in AMD and DME, with a decision by April 2025. Pre-filled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results